Brain metastases occur in as many as 50% of patients with melanoma and are associated with an "abysmal prognosis," said ...

Researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer.

Over a period of six years, Ernesto Rogata underwent extensive treatment to rid him of cancer. By the time of diagnosis, what ...

Cytophone, invented by Vladimir Zharov from the University of Arkansas for Medical Science, was originally developed as a ...

Norway ranks third in the world when it comes to the incidence of melanoma (formerly called mole cancer) and has the highest ...

Replimune Group REPL announced that it has submitted a biologics license application (BLA) to the FDA for its lead pipeline candidate, RP1, in combination with Bristol Myers’ BMY blockbuster ...

Evan Lipson, MD, an associate professor of oncology at John Hopkins School of Medicine and a head and neck oncologist at John Hopkins Medicine, discusses feedback he’s received from colleagues at Case ...

More research is needed to investigate the cause of the decline in cutaneous melanoma incidence among young patients, researchers say.

Lyell Duffy only had nine weeks with his family after a melanoma diagnosis. The family wants to help others avoid the same ...

A mum-of-two who lost her husband earlier this year to cancer is urging other families in similar circumstances to be aware ...

UVA’s melanoma trial is designed for 11 adult patients with advanced melanoma who are already getting immunotherapy and plan ...

Shares of Replimune Group topped recent 52-week highs in the after-hours market, following news the company received breakthrough therapy designation for its RP1 and submitted a biologics license ...